July 16, 2019 - Posts

Whistleblower Roundup – July 16th, 2019

A look back at the week’s news and developments affecting whistleblowers.


Reckitt Benckiser to Pay $1.4 Billion to End U.S. Opioid Addiction Treatment Probes

In the largest recovery in a case concerning an opioid drug, global consumer goods conglomerate Reckitt Benckiser has agreed to pay $1.4 billion to resolve its alleged liability in the marketing of the opioid treatment drug Suboxone. The Department of Justice alleges that Reckitt mislead health-care providers to believe that Suboxone is safer and less susceptible to abuse even though Suboxone’s active ingredient is a highly addictive opioid. The settlement resolves claims brought forward by six lawsuits under the qui tam, or whistleblower, provisions of the False Claims Act. To read the full story from the Wall Street Journal, click here.


Rural Metro of Southern Ohio Resolves False Claims Act Allegations for $275,000

Rural Metro of Southern Ohio, a medical transportation company, resolved allegations it violated the False Claims Act for $275,000. Rural Metro allegedly violated the False Claims Act by submitting false claims to Medicare for ambulance transports that were not medically necessary. To read the full DOJ press release, click here.



To learn more about our Whistleblower & Qui Tam practice click here. Our firm is located in Nashville, Tennessee but we represent whistleblowers all around the country. Call us today at (615) 244-2202.

Get in touch

Contact us today for a free consultation. We are here to work for you!